Platelet activation in patients with alcoholic liver disease

Tokai Journal of Experimental and Clinical Medicine

Volumn 30, Issue 1, 2005, Pages 41-48

  Ogasawara, Fusao ^a,c   Fusegawa, Hisae ^b   Haruki, Yasuo ^a   Shiraishi, Koichi ^a   Watanabe, Norihito ^a   Matsuzaki, Shohei ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Kanagawa National Hospital   (Japan)

^c TOKAI UNIVERSITY HACHIOJI HOSPITAL   (Japan)

Author keywords

Alcoholic liver disease; Platelet activation; Platelet microparticles

Indexed keywords

CD61 ANTIGEN; FIBRINOGEN RECEPTOR AFFECTING AGENT; PADGEM PROTEIN;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; LIVER DYSFUNCTION; MALE; MICROPARTICLE ENZYME IMMUNOASSAY; PATHOGENESIS; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

AGED; HUMANS; LIVER DISEASES, ALCOHOLIC; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; PLATELET COUNT;

EID: 18244403754     PISSN: 03850005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Adnolfi LE, Grazia M, Andreana A et al. Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis. Br J Haematology 2001; 113: 590-595.
2. Giannini E, Botta F, Borro P et al. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of esophageal varices in patients with liver cirrhosis. Gut 2003; 52: 1200-1205.
3. Nagamine T, Ohtuka T, Takehara K et al. Thrombocytopenia associated with hepatic C viral infection. J Hepatology 1996; 24: 135-140.
4. Panasiuk A, Prokopowicz D, Zak J et al. Reticulated platelets as a marker of megakaryopoiesis in liver cirrhosis: relation to thrombopoietin and hepatocyte growth factor serum concentration. Hepato-Gastroenterology 2004; 51: 1124-1128.
5. Koruk M, Onuk MD, Akcay F et al. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts. Hepato-Gastroenterology 2002; 49: 1645-1648.
6. Murawaki Y, Koda M, Okamoto K et al. Diagnostic value of serum type IV collagen test in comparison with platelet count for predicting the fibrotic stage in patients with chronic hepatitis. J Gastroenterol Hepatol 2001; 16: 777-781.
7. Arai M, Okuno F, Nagata S et al. Platelet dysfunction and alteration of prostaglandin metabolism after chronic alcohol consumption. Scand J Gastroenterol 1986; 21: 1091-1097.
8. Watanabe M, Shiraishi K, Itakura M et al. Relationship between platelet membrane lipid compositions and platelet aggregability in alcoholic liver disease. Alcholism: Clinical and Experimental Research 1998; 22: 97S-102S.
9. Pohl A, Behling C, Oliver D et al. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am J Gastroenterol 2001; 96: 3053-3055.
10. Desmet VJ, Gerber M, Hoofnagel et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520.
11. Cooper GW, Dionwitz H, Cooper B. The effects of administration of ethyl alcohol to mice on megakaryocyte and platelet development. Thromb Haemost 1984; 52: 11-14.
12. Latvala J, Parkkia S, Niemela O. Excess alcohol consumption is common in patients with cytopenia: studies in blood and bone marrow cells. Alcoholism: Clinical and Experimental Research 2004; 24: 619-624.
13. Fusegawa H, Shiraishi K, Ogasawara F et al. Platelet activation in patient with chronic hepatitis C. Tokai J Exp Clin Med 2002; 27: 101-106.
14. Sebatier F, Darmon P, Hugel B et al. Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 2002; 51: 2840-2845.
15. Lee YJ, Horstman LL, Janania J et al. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multi-infarct dementias. Thromb Res 1996; 72: 295-304.
16. Takada A et al. Comprehensive Studies A: Draft Proposal of Diagnostic Criteria for Alcoholic liver disease by The Ministry of Education in Japan 1991.
17. Shimizu M, Kamio K, Haida M et al. Platelet activation in patients with obstructive sleep apnea syndrome and effects of nasal-continuous positive airway pressure. Tokai J Exp Clin Med 2002; 24: 107-112.
18. Nomura S, Komiyama Y, Miyake T et al. Amyloid β-protein precursor-rich platelet microparticles in thrombotic disease. Thromb Haemost 1994; 72: 519-522.
19. Omoto S, Nomura S, Shouzu A et al. Detection of monocyte-derived microparticles in patient with type II diabetes mellitus. Diabetologia 2002; 45: 550-555.
20. Nguyen A, Gemmell CH, Yeo EL et al. Ethanol inhibits thrombin-induced secretion of the contents of human platelet dense and a-granules and lysosomes. Thromb Haemost 1998; 80: 662-667.
21. Davi G, Ferro D, Basili S, Iuliano L et al. Increased thromboxane metabolites excretion in liver cirrhosis. Thromb Haemost 1998; 79: 747-751.
22. Bassus S, Mahnel R, Scholz T et al. Effect of dealcoholized beer consumption on hemostasis in humans. Alcoholism: Clinical and Experimental Research 2004; 28: 786-791.
23. Miyazaki Y, Nomura S, Mitake T et al. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood 1996; 88: 3456-3464.
24. Wench JY, Lawrence LH, Manuel A. Clinical significance of platelet microparticles in autoimmune thrombocytopenia. J Lab Clin Med 1992; 119: 334-345.
25. Osumi K, Ozeki Y, Saito S et al. Development and assessment of enzyme immunoassay for platelet-derived microparticles. Thromb Haemost 2001; 85: 326-330.